share_log

中國人壽:海外監管公告 - 中國人壽保險股份有限公司2023年度財務報表及審計報告

CHINA LIFE: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Mar 27 08:13
Summary by Moomoo AI
中國人壽保險股份有限公司於2023年12月31日公佈,公司及其子公司2023年度實現營業收入344.27億元人民幣,較上年度的388.90億元有所下降。當期實現凈利潤47.55億元,較上年度的68.11億元減少。公司基本每股收益為人民幣1.63元,稀釋每股收益亦為人民幣1.63元。公司宣佈將按每股人民幣0.43元派發現金股利,共計人民幣12.15億元。此外,公司於報告期內的主要財務活動包括對子公司的增資與減資,以及與集團公司及其子公司、聯營企業和合營企業的重大關聯交易。
中國人壽保險股份有限公司於2023年12月31日公佈,公司及其子公司2023年度實現營業收入344.27億元人民幣,較上年度的388.90億元有所下降。當期實現凈利潤47.55億元,較上年度的68.11億元減少。公司基本每股收益為人民幣1.63元,稀釋每股收益亦為人民幣1.63元。公司宣佈將按每股人民幣0.43元派發現金股利,共計人民幣12.15億元。此外,公司於報告期內的主要財務活動包括對子公司的增資與減資,以及與集團公司及其子公司、聯營企業和合營企業的重大關聯交易。
CHINA LIFE INSURANCE CO., LTD. ANNOUNCED ON DECEMBER 31, 2023 THAT THE COMPANY AND ITS SUBSIDIARIES ACHIEVED AN OPERATING INCOME OF RMB344.27 BILLION IN 2023, A DECREASE FROM RMB388.90 BILLION IN THE PREVIOUS YEAR. The net profit for the period was $47.55 million, down from $68.11 billion in the previous year. The company's basic earnings per share were RMB1.63 and diluted earnings per share were RMB1.63. The company announced that cash dividends will be distributed at RMB0.43 per share, totaling RMB12.15 billion. In addition, the Company's major financial activities during the reporting period include capital increases and decreases in subsidiaries and significant associated transactions with Group companies and their subsidiaries, joint ventures and joint ventures.
CHINA LIFE INSURANCE CO., LTD. ANNOUNCED ON DECEMBER 31, 2023 THAT THE COMPANY AND ITS SUBSIDIARIES ACHIEVED AN OPERATING INCOME OF RMB344.27 BILLION IN 2023, A DECREASE FROM RMB388.90 BILLION IN THE PREVIOUS YEAR. The net profit for the period was $47.55 million, down from $68.11 billion in the previous year. The company's basic earnings per share were RMB1.63 and diluted earnings per share were RMB1.63. The company announced that cash dividends will be distributed at RMB0.43 per share, totaling RMB12.15 billion. In addition, the Company's major financial activities during the reporting period include capital increases and decreases in subsidiaries and significant associated transactions with Group companies and their subsidiaries, joint ventures and joint ventures.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more